- ￥2062
- LSM Bio
- 进口
- PAab01669
- 2025年07月15日
- ELISA,IHC,WB
- E. coli - derived recombinant protein
- Human,Mouse ,Rat
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
chondroitin polymerizing factor
- 亚型：
IgG
- 形态：
liquid
- 保存条件：
负20摄氏度
- 克隆性：
Polyclonal antibody
- 标记物：
Non-conjugated
- 适应物种：
Human,Mouse ,Rat
- 保质期：
6个月
- 抗原来源：
Rabbit
- 目录编号：
Q9GZT9
- 级别：
纯化级别
- 库存：
50
- 供应商：
LSM bio
- 宿主：
E. coli - derived recombinant protein
- 应用范围：
ELISA,IHC,WB
- 浓度：
≥95% as determined by SDS-PAGE
- 靶点：
CHPF C-Terminal
- 抗体英文名：
anti-CHPF C-Terminal antibody,CHPF C-Terminal antibody
- 抗体名：
anti-CHPF C-Terminal 抗体,CHPF C-Terminal 抗体
- 规格：
100μg
CHPF C-Terminal抗体| CHPF C-Terminal antibody
货号 PAab01669
蛋白别名 Chondroitin sulfate synthase 2 antibody, CHPF antibody, CHSY2 antibody, CSS2 antibody, FLJ22678
蛋白介绍
Has both beta-1,3-glucuronic acid and beta-1,4-N- acetylgalactosamine transferase activity. Transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Isoform 2 may facilitate PARK2 transport into the mitochondria. In collaboration with PARK2, isoform 2 may enhance cell viability and protect cells from oxidative stress.
产品描述
anti-CHPF C-Terminal antibody is a Rabbit Polyclonal antibody againstCHPF C-Terminal..
建议稀释比例
WB : 1:500-1:5000 IHC : 1:20-1:200
IHC
Immunohistochemistry of paraffin-embedded human colon cancer using PAab01669(CHPF antibody) at dilution of 1:50
Western blot
COLO 320 cells were subjected to SDS PAGE followed by western blot with PAab01669( CHPF Antibody) at dilution of 1:1000(本抗体仅供体外科研用途，不可用于临床诊断!)
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PEGylation of Antibody Fragments for Half-Life Extension
of polyethylene glycol (PEG) chain to protein using PEGylation technology. The most suitable approach employs PEG-maleimide attachment to cysteines, either to the free hinge cysteine or to C-terminal cysteines involved in interchain disulfide linkage of the heavy
Expression and Isolation of Recombinant Antibody Fragments in E. coli
linker into expression constructs to produce scFv. Further variants include the addition of a range of suitable (C-terminal) tags for the purification or detection of expressed protein, such as a human Cκ domain (scAb) (2 ), c-myc, or hexahistidine.
Cytotoxic Tumor Targeting With scFv Antibody-Modified Liposomes
that do not interfere with the receptor binding domains. Optimally, the site-specific modification is introduced at the C-terminal end of the ligand, separated by an inert spacer sequence located between the thiols and the specific part of the ligand. The thiol-reactive
技术资料暂无技术资料 索取技术资料
